News & Articles
Selected Filters:
The University of Oxford and Thermo Fisher Scientific ramp up COVID-19 testing capability
The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic
Thermo Fisher Scientific increases availability of COVID-19 testing with sample collection kit from Everlywell
The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens
Thermo Fisher Scientific launches modular closed cell processing system for cell therapy manufacturing
The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients
Thermo Fisher Scientific further expands COVID-19 test portfolio with two new antibody tests
The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts
Thermo Fisher's new LC-MS workstream offers a comprehensive solution for toxicology
Thermo Scientific Tox Explorer Collection provides instruments, columns and consumables with reliable and validated methods for reproducible results
Cancer genomic screening program LC-SCRUM-Asia adopts latest Thermo Fisher Scientific NGS solutions
Program will leverage Ion Torrent Genexus System and Oncomine Precision Assay to advance precision medicine for lung cancer in Asia
Thermo Fisher expands laboratory plastics production to support COVID-19 testing, therapies and vaccines
The company will increase production of pipette and automation tips, storage tubes and plates, transfer pipettes, and packaging for vials and bottles
Thermo Fisher announces collaborations to meet unmet clinical needs in biomarker discovery and characterization
Agreements with AstraZeneca and the University of Nebraska Medical Center showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis
First FDA Approved CDx for RET fusion-positive metastatic non-small cell lung cancer (NSCLC)
This makes the Oncomine Dx Target Test the first NGS-based companion diagnostic for RET fusion-positive NSCLC and expands the test’s utility
FDA approves first NGS-based companion diagnostic for RET fusion-positive non-small cell lung cancer
CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO
New deployment model optimizes LIMS implementation in the Amazon Web Services Cloud
Thermo Fisher’s cloud services enable easy, cost-effective, compliant and secure cloud deployment of Thermo Scientific SampleManager LIMS software
Next-generation remote monitoring solution supports uncompromised sample safety and integrity
The Thermo Scientific Smart-Vue Pro Remote Monitoring Solution protects samples, improves laboratory efficiency and facilitates regulatory compliance
Thermo Fisher Scientific introduces hematology-oncology portfolio for Ion Torrent Genexus System
The new assays are designed to enable turnaround times for next-generation sequencing results of less than 24 hours
Thermo Fisher Scientific launches compact ion chromatography system designed to streamline water analysis
Thermo Scientific Dionex Easion Ion Chromatography System is designed to reduce total cost of ownership and need for maintenance
Thermo Fisher Scientific signs companion diagnostic agreement with Hengrui Therapeutics, Inc.
Companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib
Thermo Fisher Scientific develops COVID-19 antibody assay targeting transplant community
This powerful new solution aims to provide more accurate COVID-19 antibody detection
Thermo Fisher Scientific's COVID-19 response continues to expand with new high-throughput automated testing solution
The modular solution aims to deliver test results in a four-step process requiring minimal hands-on time, laboratory space and staffing resources













